News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
42,720 Results
Type
Article (2730)
Company Profile (45)
Press Release (39944)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (15400)
Career Advice (81)
Deals (2307)
Drug Delivery (9)
Drug Development (4318)
Employer Resources (10)
FDA (458)
Job Trends (826)
News (21792)
Policy (1116)
Tag
Academia (147)
Accelerated approval (1)
Allergies (10)
Alliances (3597)
ALS (10)
Alzheimer's disease (68)
Antibody-drug conjugate (ADC) (33)
Approvals (462)
Artificial intelligence (39)
Autoimmune disease (11)
Automation (2)
Bankruptcy (13)
Best Places to Work (504)
BIOSECURE Act (2)
Biosimilars (16)
Biotechnology (29)
Bladder cancer (8)
Brain cancer (8)
Breast cancer (48)
Cancer (357)
Cardiovascular disease (10)
Career advice (68)
Career pathing (1)
CAR-T (35)
CDC (1)
Cell therapy (89)
Cervical cancer (2)
Clinical research (3616)
Collaboration (218)
Company closure (2)
Compensation (104)
COVID-19 (194)
CRISPR (12)
C-suite (144)
Cystic fibrosis (9)
Data (444)
Denatured (6)
Depression (12)
Diabetes (20)
Diagnostics (523)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (40)
Drug pricing (10)
Duchenne muscular dystrophy (40)
Earnings (5187)
Editorial (5)
Employer branding (1)
Employer resources (9)
Events (6547)
Executive appointments (165)
FDA (637)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (201)
Gene editing (36)
Generative AI (2)
Gene therapy (64)
GLP-1 (67)
Government (170)
Guidances (38)
Healthcare (793)
HIV (1)
Huntington's disease (5)
IgA nephropathy (13)
Immunology and inflammation (38)
Immuno-oncology (14)
Indications (5)
Infectious disease (206)
Inflammatory bowel disease (17)
Inflation Reduction Act (6)
Influenza (8)
Intellectual property (29)
Interviews (7)
IPO (1126)
IRA (7)
Job creations (305)
Job search strategy (64)
JPM (8)
Kidney cancer (6)
Labor market (15)
Layoffs (59)
Leadership (3)
Legal (222)
Liver cancer (6)
Longevity (1)
Lung cancer (31)
Lymphoma (13)
Machine learning (4)
Management (4)
Manufacturing (59)
MASH (16)
Medical device (376)
Medtech (377)
Mergers & acquisitions (1319)
Metabolic disorders (78)
Multiple sclerosis (24)
Neurodegenerative disease (29)
Neuropsychiatric disorders (11)
Neuroscience (185)
NextGen: Class of 2026 (375)
Non-profit (164)
Now hiring (11)
Obesity (34)
Opinion (21)
Ovarian cancer (18)
Pain (28)
Pancreatic cancer (24)
Parkinson's disease (14)
Partnered (5)
Patents (55)
Patient recruitment (35)
Peanut (2)
People (6487)
Pharmaceutical (5)
Phase 1 (1532)
Phase 2 (1790)
Phase 3 (968)
Pipeline (513)
Policy (16)
Postmarket research (31)
Preclinical (663)
Press Release (2)
Prostate cancer (8)
Psychedelics (3)
Radiopharmaceuticals (19)
Rare diseases (69)
Real estate (429)
Recruiting (6)
Regulatory (989)
Reports (8)
Research institute (154)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (5)
RSV (1)
Schizophrenia (16)
Series A (54)
Series B (25)
Service/supplier (2)
Sickle cell disease (5)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (519)
Stomach cancer (2)
Supply chain (5)
Tariffs (2)
The Weekly (3)
Vaccines (57)
Venture capital (20)
Weight loss (21)
Women's health (11)
Worklife (1)
Date
Last 7 days (47)
Last 30 days (190)
Last 365 days (2797)
2026 (280)
2025 (2778)
2024 (2868)
2023 (3135)
2022 (4036)
2021 (4320)
2020 (3715)
2019 (2264)
2018 (1705)
2017 (1925)
2016 (1696)
2015 (1905)
2014 (1430)
2013 (1215)
2012 (1421)
2011 (1355)
2010 (1226)
Location
Africa (46)
Alabama (4)
Arizona (20)
Asia (2065)
Australia (345)
California (1702)
Canada (263)
China (89)
Colorado (58)
Connecticut (21)
Delaware (13)
Europe (4496)
Florida (79)
Georgia (13)
Hawaii (2)
Idaho (3)
Illinois (26)
India (2)
Indiana (62)
Iowa (1)
Japan (18)
Kansas (16)
Kentucky (1)
Maryland (60)
Massachusetts (673)
Michigan (19)
Minnesota (25)
Mississippi (1)
Missouri (5)
Nebraska (1)
Nevada (4)
New Hampshire (5)
New Jersey (155)
New Mexico (1)
New York (121)
North Carolina (146)
Northern California (835)
Ohio (49)
Oklahoma (4)
Oregon (7)
Pennsylvania (133)
Puerto Rico (1)
Rhode Island (4)
South America (42)
South Carolina (1)
Southern California (687)
Tennessee (4)
Texas (183)
United States (3609)
Utah (10)
Virginia (14)
Washington D.C. (3)
Washington State (109)
West Virginia (1)
Wisconsin (13)
42,720 Results for "inflection biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Hoth Therapeutics Reaches Key EU Regulatory Inflection Point Advancing HT-001 Oncology Trial Toward Multi-Country Site Activation
January 16, 2026
·
5 min read
Press Releases
Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point
December 18, 2025
·
4 min read
Opinion
DMD Gene Therapy’s Inflection Point and the Case for Small Molecules
As AAV9 and CRISPR programs navigate safety, delivery and scalability hurdles, small molecules offer a deployable, scalable bridge, complementing genetic approaches and accelerating meaningful impact for patients with Duchenne muscular dystrophy.
September 4, 2025
·
6 min read
·
David Craig
Press Releases
Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround
July 2, 2025
·
8 min read
Press Releases
MedX Holdings, Inc. (OTC: MEDH) Med X Holdings Q2 2025 Investor Update: We’re at an Inflection Point
August 20, 2025
·
5 min read
Layoffs
Sutro Makes Deeper Cuts To Extend Runway Into 2027, Reach Key Data Readout
After parting with 50% of its employees earlier this year, Sutro Biopharma will lay another third of its staff in a restructuring effort geared toward reaching key inflection points.
September 30, 2025
·
1 min read
·
Dan Samorodnitsky
Drug Development
Molecular Glue Degraders at Inflection Point as Pharma Dives In
Novartis, Biogen, Takeda and Novo Nordisk are all betting on advances in the molecular glue degraders space, collectively investing billions in hopes of treating cancer, Alzheimer’s disease, cardiometabolic disease and more.
December 16, 2024
·
6 min read
·
Kate Goodwin
Press Releases
Change in Number of Shares and Votes in Alligator Bioscience AB
February 1, 2026
·
1 min read
Press Releases
Imbed Biosciences Secures Strategic Investment from BioLab Holdings
February 4, 2026
·
2 min read
Press Releases
Invitation to Alligator Bioscience’s Earnings Call on 12 February 2026
February 5, 2026
·
1 min read
1 of 4,272
Next
